SEC v. Gregory Lemelson, Lemelson Capital Management, LLC, and The Amvona Fund (short and distort, 2018)
Judgment entered
Checked against the primary document on October 4, 2026. The library's summary, tags and figures for this record were compared with the regulator's own document by an AI model (Claude) following written instructions, with sampled and disputed records read a second time. No lawyer has reviewed them. A checked record can still contain errors, and checked does not mean endorsed. See how we check records or report a correction.
In September 2018 the SEC sued hedge fund adviser Gregory Lemelson and Lemelson Capital Management over allegedly false statements about Ligand Pharmaceuticals. A Boston jury found them liable on three statements in November 2021, and on 30 March 2022 the court entered a final judgment with a five-year injunction and a $160,000 penalty against Lemelson.
The record
| Agency | SEC |
|---|---|
| Release number | LR-24267 |
| Date filed | 2018-09-13 |
| Date resolved | 2022-03-30 |
| Court | U.S. District Court, District of Massachusetts |
| Status | judgment |
| Asset class | equities |
| Criminal parallel | No |
| Bars imposed | conduct-based injunction |
| Defendants | Gregory Lemelson ; Lemelson Capital Management, LLC ; The Amvona Fund |
| Cited as charged or alleged | Advisers Act s.206 ; Exchange Act s.10(b) and Rule 10b-5 |
| Techniques | Short and distort |
What was ordered
- Civil penalty
- $160k
- Disgorgement
- —
- Prejudgment interest
- —
- Total relief
- $160k
- Alleged gain
- $1.3m
What is alleged to have happened
the Securities and Exchange Commission announced this matter on September 13, 2018 as release LR-24267. The respondents named are Gregory Lemelson, Lemelson Capital Management, LLC and The Amvona Fund (1 individual, 2 entities). The action was brought in the U.S. District Court, District of Massachusetts.
This library tags the matter as short and distort, based on the conduct the regulator describes. Each tag links to a page explaining how that technique works, what statute it engages, and what penalties comparable actions have attracted. The tagging is ours, not the regulator's: agencies charge statutory provisions, not technique names.
The conduct is recorded against equities.
Two later SEC litigation releases show the case went to trial. On 5 November 2021 a jury in Boston found Lemelson and his firm liable for three false or misleading statements about Ligand, while not finding them liable on certain other charges and allegations. On 30 March 2022 the District of Massachusetts entered a final judgment enjoining both from antifraud violations for five years and ordering Lemelson to pay a $160,000 civil penalty. The SEC's releases state no disgorgement or interest, and they do not address The Amvona Fund, a named defendant. We did not check whether the judgment was appealed.
What technique is this, and how does it work?
This action is tagged with one technique in our taxonomy. The tagging is ours: regulators charge statutory provisions, not technique names, so the mapping is an editorial judgement described in our editorial policy.
- Short and distort — see how it works, what statute it engages, and every other action tagged the same way.
Timeline
- 2018-09-13 Litigation release published
- 2021-11-05 Jury finds Lemelson and Lemelson Capital Management liable on three false statements
- 2022-03-30 Final judgment entered: five-year injunction and $160,000 penalty against Lemelson
Primary documents
Everything on this page derives from the documents below. Where our summary and the primary document disagree, the primary document is right.
- SEC litigation release
- SEC litigation release LR-25258 (jury verdict)
- SEC litigation release LR-25353 (final judgment)
Same matter
The library links these 3 records because they appear to concern one matter: the same lead defendant, an overlapping technique tag and close filing dates, or a shared court docket or a release that cites the other. Records are listed by date filed.
| Date filed | Agency | Record | Status |
|---|---|---|---|
| 2018-09-13 | SEC | SEC v. Gregory Lemelson, Lemelson Capital Management, LLC, and The Amvona Fund (short and distort, 2018) | Judgment entered |
| 2021-11-08 | SEC | SEC v. Gregory Lemelson, Lemelson Capital Management, LLC, and The Amvona Fund (short and distort, 2021) | Judgment entered |
| 2022-03-31 | SEC | SEC v. Gregory Lemelson, Lemelson Capital Management, LLC, and The Amvona Fund (short and distort, 2022) | Judgment entered |
Related actions
Other actions in the library sharing at least one technique tag with this one.
| Action | Agency | Filed | Technique | Penalty | Status |
|---|---|---|---|---|---|
| SEC v. Gregory Lemelson, Lemelson Capital Management, LLC, and The Amvona Fund (short and distort, 2022) | SEC | 2022-03-31 | Short And Distort | $160k | judgment |
| SEC v. Gregory Lemelson, Lemelson Capital Management, LLC, and The Amvona Fund (short and distort, 2021) | SEC | 2021-11-08 | Short And Distort | — | judgment |